Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Immunologic Techniques × Clear all

NCT00343109 2020-02-12

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male